Clinical Trial Update: An Evaluation of the Safety and Efficacy of Memantine in Patients With Acute Mania Associated With Bipolar I Disorder [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and efficacy of memantine for acute mania in Bipolar I Disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Namenda (memantine)

Snippet

Sponsor: Forest Laboratories | Conditions: Bipolar Disorder | Phase 2 | Status: COMPLETED